Treatment costs for Glioblastoma Multiforme in Nova Scotia

Canadian Journal of Neurological Sciences

Volumn 28, Issue 1, 2001, Pages 61-65

  Mendez, I ^a   Jacobs, P ^a   MacDougall, A ^a   Schultz, M ^a  

^a QUEEN ELIZABETH II HEALTH SCIENCES CENTRE   (Canada)

Author keywords

[No Author keywords available]

Indexed keywords

ANTINEOPLASTIC AGENT;

ADULT; AGED; ARTICLE; CANADA; CANCER CHEMOTHERAPY; CANCER MORTALITY; CANCER RADIOTHERAPY; CANCER SURGERY; CANCER SURVIVAL; COST BENEFIT ANALYSIS; COST OF ILLNESS; FEMALE; GLIOBLASTOMA; HEALTH CARE COST; HOSPITAL COST; HUMAN; MAJOR CLINICAL STUDY; MALE; MEDICAL CARE; PRIORITY JOURNAL; SURVIVAL TIME;

EID: 0035106673     PISSN: 03171671     EISSN: None     Source Type: Journal    
DOI: 10.1017/S0317167100052574     Document Type: Article

References (21)

1. The geographic distribution of glioblastoma multiforme in Nova Scotia
2. Intracranial astrocytomas: Concepts and therapy
3. Which glioblastoma multiforme patient will become a long-term survivor? A population-based study
4. High grade astrocytomas: Resource use, clinical outcomes, and cost of care
5. The cost effectiveness of stereotactic radiosurgery versus surgical resection in the treatment of solitary metastatic brain tumors
6. Cost and survival analysis of metastatic cerebral tumors treated by resection and radiation
7. Cost-utility analysis of a malignant glioma protocol
8. The cost of managing patients with malignant glioma at a neuro- oncology clinic
9. A cost-effectiveness and cost-utility analysis of radiosurgery vs. resection for single brain metastases
10. Medical care at the end of life: The interaction of economics and ethics
11. Trends in medicare payments in the last year of life
12. The incidence and economic costs of cancer, motor vehicle injuries, coronary heart disease, and stroke: A comparative analysis
13. Influence of location and extent of surgical resection on survival of patients with glioblastoma multiforme: Results of three consecutive radiation therapy oncology group (RTOG) clinical trials
14. Contemporary approaches to the treatment of malignant gliomas with radiation treatment
15. Management of primary malignant brain tumor
16. The basis for current treatment recommendations for malignant gliomas
17. Evaluation of BCNU and /or radiotherapy in the treatment of anaplastic gliomas: A cooperative clinical trial
18. Decision framework for chemotherapeutic interventions for metastatic non-small-cell lung cancer
19. Placebo-controlled trail of safety and efficacy of intraoperative controlled delivery by biodegradable polymers of chemotherapy for recurrent gliomas
20. Interstitial Chemotherapy with Carmustine-loaded polymers for high-grade gliomas: A randomized double-blind study